Medicare Could Collect Billions Via Drug Co. Rebates: OIG

Law360, New York (September 10, 2013, 6:34 PM EDT) -- An Office of Inspector General’s report Tuesday found that Medicare could save more than $3 billion annually under a limited expansion of drug rebates that currently apply only to Medicaid, but federal regulators say they have no intention of pursuing the idea, citing various technical challenges.

The report focused on a narrow rebate expansion that would cover the relatively modest number of drugs paid for by Medicare Part B, where 60 medicines account for 85 percent of roughly $16 billion in yearly expenditures. In contrast, the...
To view the full article, register now.